Clinical Trial Investigative Site Network Market was valued at USD 9.2 Bn in 2025 and is projected to reach USD 18.7 Bn by ...

Threat actors are exploiting misconfigured web applications used for security training and internal penetration testing, such ...

Alphabet Inc. tops $4T as Gemini, TPUs and Google Cloud surge. Click for this updated look at GOOG stock following the big ...

The report on Uveitis clinical trials highlights opportunities in understanding trial count, enrollment trends, and successful trial regions. It aids strategic investment decisions by identifying key ...

Opportunities lie in strategic investment formulation, identifying cost-effective locations for conducting trials, understanding global trial trends, and analyzing trial success rates. Insights into ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

The PSMA-targeted therapy market is expected to grow strongly, fueled by higher prostate cancer diagnosis rates, improved awareness of PSMA-based treatments, and an expanding clinical trial landscape ...

HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...

The main market opportunities include identifying key locations for cost-effective clinical trials, understanding global trial success rates, and analyzing enrollment trends and competitive dynamics.

| DelveInsight The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...